Searchable abstracts of presentations at key conferences in endocrinology

ea0063p19 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Allgrove syndrome (Triple A syndrome): A case report

Moustafa Heba , El Gohary Amira M , Essam Kareem , Fatah Yasmine Abd El , Salam Randa F

Introduction: Allgrove syndrome is a rare autosomal recessive disorder characterized by a Lacrima, achalasia, adrenal Insufficiency and Neurologic disorders. Mutation in (AAAS) gene on chromosome 12q13, has been implicated.Case report: Eighteen-year-old male referred to the Endocrinology clinic for evaluation of suspected adrenal insufficiency. The patient reported generalized weakness, fatigue, anorexia recurrent fainting attacks, and progressive hyperp...

ea0073aep25 | Adrenal and Cardiovascular Endocrinology | ECE2021

Oral and dental manifestation of Allgrove syndrome: A case report

Dhoha Ben Salah , Charfi Hana , Mouna Elleuch , Wajdi Safi , Fatma Mnif , Mouna Mnif , Nadia Charfi , Nabila Rekik , Faten Hadj Kacem , Mohamed Abid

IntroductionTriple-A syndrome, also known as Allgrove syndrome, is a rare autosomal recessive disorder. It is a multisystemic disease with an estimated prevalence of 1 per 1 000 000 individuals The 3 features of this syndrome are achalasia, adrenal insufficiency, and alacrima. Recently, dental impairment has been the subject of several case reports and reviews. However, this abnormality remains under-diagnosed.Purpose<p class="...

ea0093oc13 | Oral communication 2: Neuroendocrinology | EYES2023

Hypogonadotropic hypogonadism in a patient with Allgrove syndrome: A case report

Gheorghe-Milea Ana , Rusu Eva , Stănoiu-Pinzariu Oana , Georgescu Carmen Emanuela

Background: Triple A (Allgrove) syndrome is a rare genetic disorder with autosomal recessive inheritance, caused by mutations in the AAAS gene on chromosome 12q13. It is characterized by the following triad: ACTH-resistant adrenal insufficiency, alacrimia, and achalasia.Case presentation: We present the case of a 19-year-old male who was diagnosed with adrenal insufficiency at the age of five following an addisonian crisis with hypoglycemic coma. At the ...

ea0033cme1 | CME TRAINING DAY | BSPED2013

Bone physiology or calcium and phosphate metabolism

Allgrove J

Bone has three main components: matrix, mostly made up of type 1 collagen, mineral, which is laid down on the matrix by osteoblasts, and bone cells: osteoclasts, which are derived from haemopoietic precursors, osteoclasts, which are of fibroblast precursor origin, and osteocytes, the most numerous, which are derived from osteoblasts.Osteoblasts operate under the influence of several humoral factors including PTH, 1,25(OH)2D and cytokines which...

ea0024s19 | Symposium 2 – Metabolic Bone Disease | BSPED2010

New developments in phosphate metabolism: understanding the mechanisms of hypophosphataemic rickets

Allgrove Jeremy

During the past ten years there has been an explosion of understanding of the metabolism of phosphate which centres around fibroblast growth factor 23 which is now thought to be the ‘phosphotonin’ that had long been suspected.Discovery of this hormone, which is synthesised by osteocytes, is secreted and circulates in plasma, therefore qualifying it as a true hormone, has led to an understanding of the mechanisms of the various forms of hypophos...

ea0017oc13 | Diabetes 1 | BSPED2008

Children with Type 1 diabetes should be screened for lipid abnormalities at annual review

Howard S , Allgrove J

Background: Hypercholesterolaemia has been identified as a major risk factor for cardiovascular disease in adults with Diabetes Mellitus (DM), and studies have shown evidence of raised lipid levels in children with Diabetes. However, current NICE guidelines state that ‘Routine screening for elevated blood lipid levels is not recommended for children and young people with type 1 diabetes’; although ISPAD and APEG recommendations are for lipid screening in those over 1...

ea0039ep20 | Bone | BSPED2015

Early onset cataract in an infant with activating calcium-sensing receptor mutation

Ramaswamy Priya , Ryalls Mike , Allgrove Jeremy

We present a 3-month-old boy who was born at term, to non-consanguineous parents by spontaneous vaginal delivery, weighing 4.19 kg. Newborn examination, including eyes, was normal. He was admitted at 7 days of life with focal seizures and hypocalcaemia, hypomagnesaemia, hyperphosphataemia, and inappropriately low parathyroid hormone (PTH) levels. He was treated with i.v. calcium and magnesium infusions and discharged on oral calcium, magnesium, and alfacalcidol. He was re-admi...

ea0034p410 | Thyroid | SFEBES2014

PTEN hamartoma syndrome: unravelling the complexities of childhood surveillance

Katugampola Harshini , Howard Sasha , Allgrove Jeremy

Background: PTEN hamartoma tumour syndrome (PHTS) is a rare autosomal dominant disorder characterised by macrocephaly and multiple hamartomas. It carries an increased risk of several cancers, including breast, thyroid and endometrium. PHTS is caused by inactivating mutations of PTEN (phosphate and tensin homologue deleted on chromosome 10), which encodes a tumour suppressor phosphatase. Published guidelines for surveillance are available for adult patients but not adv...

ea0033p86 | (1) | BSPED2013

PTEN hamartoma syndrome: unravelling the complexities of childhood screening

Katugampola Harshini , Howard Sasha , Allgrove Jeremy

Background: PTEN hamartoma tumour syndromes (PHTS) are rare autosomal dominant inherited disorders characterised by macrocephaly, multiple hamartomas and an increased risk of several cancers, including breast, thyroid and endometrium. PTEN encodes a tumour suppressor phosphatase that regulates cell survival and migration. Published guidelines are available for adult patients but screening in children is currently not standardised. Moreover, there is poor genotype-phenotype cor...